Ankur Drugs & Pharma Ltd.

Name: Ankur Drugs & Pharma Ltd. Share Price Today, Stock Analysis
Brand: Ankur Drugs & Pharma Ltd.

Stock Card

NSE: ANKURDRUGS | BSE: 531683

₹3.65

₹-0.15 (-3.95%)

As on 10-Sep-2013IST

Market cap

₹8 Cr

Revenue (TTM)

₹143 Cr

P/E Ratio

P/B Ratio

-0

Div. Yield

0 %

Ankur Drugs & Pharma Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 3.65 High: 3.75

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹-307 Cr
ROE

-328.5 %
ROCE

-16 %
Industry P/E

42.09
EV/EBITDA

-16.8
Debt to Equity

-17.1
Book Value

₹--
EPS

₹-127.9
Face value

10
Shares outstanding

19,341,590

10 Years Aggregate

CFO

₹907.61 Cr

EBITDA

₹654.00 Cr

Net Profit

₹-133.86 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Ankur Drugs & Pharma	-70.9	-8.8	-41.1	-70.8	-70.8	-56.4	--
BSE Sensex^*	-9.1	-1.5	2.9	-3.6	5.9	6.0	10.5
BSE Healthcare^#	18.1	1.0	9.6	17.6	22.5	14.1	12.2

As on 10-Sep-2013 | *As on 01-Sep-2026 | #As on 01-Sep-2026

The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Ankur Drugs & Pharma	3.7	7.6	142.8	-247.4	-92.9	-100	--	0.0
Acutaas Chemicals	3,174.3	25,979.8	1,461.8	387.4	34.5	25.2	67.3	15.1
Alembic Pharma	843.9	16,595.8	7,784.0	688.5	10.6	14	23.9	2.8
Cohance Lifesciences	460.0	17,589.9	2,141.5	58.5	5.8	3.3	165.6	4.6
Granules India	837.2	20,755.5	5,632.3	662.4	17.2	14.3	31.3	4.2
Onesource Specialty Pharma	1,527.9	17,502.0	1,543.3	-48.6	3.6	-0.6	--	3.0
Piramal Pharma	213.2	28,384.3	9,205.3	-371.8	1.7	-3.8	--	3.5
Rubicon Research	1,822.2	30,127.6	1,935.8	288.2	20.6	29.8	104.5	22.4
Syngene Intl	402.1	16,213.4	3,600.2	221.0	9.7	5.6	73.4	3.4
Wockhardt	1,850.6	30,074.9	3,564.0	414.0	15.3	8.4	73.5	6.0

Shareholding Pattern

View Details

News & Analysis

All News

No Review & Analysis are available.

About Ankur Drugs & Pharma

Manufacture of allopathic pharmaceutical preparations

Incorporated

1995
Chairman

Purnandu Jain
Managing Director

Purnandu Jain
Headquarters

Mumbai, Maharashtra
Website

www.ankurdrugs.com

FAQs for Ankur Drugs & Pharma

What is the current share price of Ankur Drugs & Pharma Ltd Today?

The share price of Ankur Drugs & Pharma Ltd is ₹3.65 (NSE) and ₹3.93 (BSE) as of 10-Sep-2013 IST. Ankur Drugs & Pharma Ltd has given a return of -70.76% in the last 3 years.

What is the current PB & PE ratio of Ankur Drugs & Pharma Ltd?

Since, TTM earnings of Ankur Drugs & Pharma Ltd is negative, P/E ratio is not available.
The P/B ratio of Ankur Drugs & Pharma Ltd is -0.04 times as on 05-Sep-2013, a 101 discount to its peers’ median range of 4.27 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2012	0.00	-0.49
2011	0.00	0.41
2010	4.54	1.23
2009	3.46	0.49
2008	3.62	1.09

What is the 52 Week High and Low of Ankur Drugs & Pharma Ltd?

The 52-week high and low of Ankur Drugs & Pharma Ltd are Rs -- and Rs -- as of 02-Sep-2026.

What is the market cap of Ankur Drugs & Pharma Ltd?

Ankur Drugs & Pharma Ltd has a market capitalisation of ₹ 8 Cr as on 05-Sep-2013. As per SEBI classification, it is a company.

Should I invest in Ankur Drugs & Pharma Ltd?

Before investing in Ankur Drugs & Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.